logo

For the Inventor, By the Inventor

Täby, Sweden

Martin Haraldsson

This inventor holds 7 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Proximagen Limited, Thomas Helledays Stiftelse for Medicinsk Forskning, Amgen Inc.. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Haraldsson. Retrieved from https://idiyas.com/inventor/martin-haraldsson-us5vvfgr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 57.1

 

Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 20(Granted Patents)


Location History:

  • Taby, SE (2010)
  • Stockholm, SE (2015 - 2016)
  • Täby, SE (2021 - 2023)

Company Filing History:

goldMedal2 out of 38 
 
Proximagen Limited
 patents
silverMedal2 out of 10 
 
Thomas Helledays Stiftelse for Medicinsk Forskning
 patents
bronzeMedal1 out of 2,074 
 
Amgen Inc.
 patents
4. 1 out of 55 
 
Biovitrum Ab
 patents
5. 1 out of 1 
 
Genase Therapeutics B.v.
 patent

Years Active: 2010-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 12357634 - 2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy (2025-07-15),
2. 11795157 - Tetrahydroindazoles and medical uses thereof (2023-10-24),
3. 11504368 - 2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy (2022-11-22),
4. 10889564 - Tetrahydroindazoles and medical uses thereof (2021-01-12),
5. 9227967 - Inhibitor compounds of semicarbazide-sensitive amine oxidases (2016-01-05),
6. 9150574 - Enzyme inhibitor compounds (2015-10-06),
7. 7666888 - Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1 (2010-02-23),

Title: Martin Haraldsson: Innovator in Pharmaceutical Compounds

Introduction

Martin Haraldsson is a notable inventor based in Täby, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for therapeutic use. With a total of 7 patents to his name, Haraldsson's work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Among his latest patents, Haraldsson has developed compounds such as 2,6-diamino-3,4-dihydropyrimidin-4-one derivatives. These compounds are useful in therapy for treating cancers, inflammation, autoimmune diseases, and graft-versus-host diseases, particularly in transplantation patients. Additionally, he has patented tetrahydroindazoles, which are intended for the treatment of cancer and the prevention of viral infections.

Career Highlights

Throughout his career, Martin Haraldsson has worked with esteemed organizations, including the Thomas Helledays Foundation for Medical Research and Proximagen Limited. His innovative research has positioned him as a key figure in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Haraldsson has collaborated with notable colleagues, including Lars Sandberg and Marianne Nilsson. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Martin Haraldsson's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through research and development. His patents reflect a dedication to finding effective treatments for serious medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…